Tags

Type your tag names separated by a space and hit enter

Immunogenicity of purified vero cell rabies vaccine used in the treatment of fox-bite victims in India.
Clin Infect Dis. 2005 Feb 15; 40(4):611-3.CI

Abstract

Purified Vero cell rabies vaccine was used to treat 19 patients who experienced fox bite. Seventeen patients survived, and 2 patients died of rabies. Maximum antibody titers determined using a rapid fluorescent focus inhibition test were 25 IU, < or =90 days after the first vaccination and were 30 IU on day 1050 after booster vaccination.

Authors+Show Affiliations

District Hospital, Nashik, India. indhu-matha@yahoo.comNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

15712086

Citation

Matha, I S., and S R. Salunke. "Immunogenicity of Purified Vero Cell Rabies Vaccine Used in the Treatment of Fox-bite Victims in India." Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America, vol. 40, no. 4, 2005, pp. 611-3.
Matha IS, Salunke SR. Immunogenicity of purified vero cell rabies vaccine used in the treatment of fox-bite victims in India. Clin Infect Dis. 2005;40(4):611-3.
Matha, I. S., & Salunke, S. R. (2005). Immunogenicity of purified vero cell rabies vaccine used in the treatment of fox-bite victims in India. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America, 40(4), 611-3.
Matha IS, Salunke SR. Immunogenicity of Purified Vero Cell Rabies Vaccine Used in the Treatment of Fox-bite Victims in India. Clin Infect Dis. 2005 Feb 15;40(4):611-3. PubMed PMID: 15712086.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Immunogenicity of purified vero cell rabies vaccine used in the treatment of fox-bite victims in India. AU - Matha,I S, AU - Salunke,S R, Y1 - 2005/01/26/ PY - 2004/08/13/received PY - 2004/09/22/accepted PY - 2005/2/16/pubmed PY - 2006/3/31/medline PY - 2005/2/16/entrez SP - 611 EP - 3 JF - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America JO - Clin Infect Dis VL - 40 IS - 4 N2 - Purified Vero cell rabies vaccine was used to treat 19 patients who experienced fox bite. Seventeen patients survived, and 2 patients died of rabies. Maximum antibody titers determined using a rapid fluorescent focus inhibition test were 25 IU, < or =90 days after the first vaccination and were 30 IU on day 1050 after booster vaccination. SN - 1537-6591 UR - https://www.unboundmedicine.com/medline/citation/15712086/Immunogenicity_of_purified_vero_cell_rabies_vaccine_used_in_the_treatment_of_fox_bite_victims_in_India_ L2 - https://academic.oup.com/cid/article-lookup/doi/10.1086/427700 DB - PRIME DP - Unbound Medicine ER -